Elshad Hasanov Selected Research

Autoimmune Diseases (Autoimmune Disease)

5/2024

Special populations in metastatic renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elshad Hasanov Research Topics

Disease

9	Renal Cell Carcinoma (Grawitz Tumor) 10/2023 - 01/2018
6	Neoplasms (Cancer) 05/2024 - 01/2018
3	von Hippel-Lindau Disease (von Hippel Lindau Disease) 04/2022 - 05/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2021
2	Brain Neoplasms (Brain Tumor) 10/2023 - 03/2021
2	Disease Progression 10/2023 - 12/2019
2	Breast Neoplasms (Breast Cancer) 03/2021 - 08/2017
2	Fatigue 12/2019 - 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 05/2024
1	Neoplasm Metastasis (Metastasis) 05/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2023
1	Microsatellite Instability 04/2022
1	Necrosis 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2021
1	Hemangioblastoma 05/2021
1	Circulating Neoplastic Cells 01/2021
1	Kidney Neoplasms (Kidney Cancer) 09/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Musculoskeletal Pain 12/2019
1	Hyperkalemia 12/2019
1	Leukopenia 12/2019
1	Lymphopenia (Lymphocytopenia) 12/2019
1	Anemia 12/2019
1	Diarrhea 01/2018
1	Hand-Foot Syndrome 01/2018
1	Urinary Incontinence 08/2017

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 05/2024 - 09/2020
2	belzutifanIBA 04/2022 - 05/2021
2	endothelial PAS domain-containing protein 1IBA 04/2022 - 05/2021
2	NivolumabIBA 01/2022 - 01/2021
2	IpilimumabIBA 01/2022 - 01/2021
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 10/2023
1	Indicators and Reagents (Reagents)IBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	cabozantinibIBA 12/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	atezolizumabIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Cytidine Triphosphate (CTP)IBA 01/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	CytokinesIBA 01/2021
1	Everolimus FDA Link 01/2020
1	carfilzomibIBA 12/2019
1	CreatinineIBA 12/2019
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 05/2018
1	Sunitinib (Sutent)FDA Link 01/2018
1	Hormones (Hormone)IBA 08/2017
1	Tamoxifen FDA LinkGeneric 08/2017
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2017
1	Estrogens (Estrogen)FDA Link 08/2017

Therapy/Procedure

11	Therapeutics 05/2024 - 01/2018
4	Immunotherapy 10/2023 - 09/2020
1	Drug Tapering 01/2018